Les meilleurs CT (tomodensitométrie) en Israël pour votre CT (tomodensitométrie) - TOP 34 des médecins

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Alon Friedlander, MD, is an orthopedic surgeon and a spine and scoliosis specialist for adults and children. He is the Director of the Orthopedic Department at Sheba Medical Center. He is also an Associate Professor of Orthopedics at Tel Aviv University. He is listed by Forbes among Israel’s Top Doctors.

He treats complex spine disorders with minimally invasive and open surgery. His procedures include anterior and posterior fixation. His focus areas are scoliosis and other deformities, tumors, stenosis and instability, and disc herniation. Education: MD, Tel Aviv University; residency, Sheba Medical Center. Fellowships: Institut Mutualiste Montsouris and University Hospitals of Strasbourg (France); Queen Mary Hospital and the Duchess of Kent Children’s Hospital (Hong Kong).

Advisory roles: IDF referral physician. Consultant to soccer teams. Specialist for the Spartak Basketball Club (knee injuries).

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Professor Dov Zippel is a general surgeon and surgical oncologist. He specializes in breast disease and melanoma. He leads the Meirav Breast Center at Sheba Medical Center. He also serves at the Ella Lemelbaum Institute for Immuno-Oncology. In 2025, Forbes Israel named him to its Best Doctors list.

Expertise: advanced care for benign and malignant breast tumors. Minimally invasive and breast-conserving surgery. Surgical treatment of melanoma and other skin cancers.

Accreditations: MD, Tel Aviv University. Residency in general surgery, Sheba Medical Center. Fellowship in surgical oncology, University of Calgary. Board-certified in general surgery and surgical oncology. Research includes intact breast lesion excision and perioperative BRAF inhibitors for stage III melanoma.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Le médecin est un spécialiste de premier plan dans le diagnostic et le traitement des cancers gynécologiques, y compris le cancer de l'ovaire, de l'utérus et du col de l'utérus. Le médecin mène des recherches sur les causes du cancer du col de l'utérus et le diagnostic du cancer de l'ovaire, en se concentrant sur les marqueurs précoces et les thérapies ciblées.<\/p>

Actuellement, le médecin est médecin principal dans le département d'oncologie gynécologique et dirige le département d'obstétrique et de gynécologie au Centre Médical Ichilov Sourasky. Le médecin est également maître de conférences et professeur associé à l'Université de Tel Aviv.<\/p>

Avec 39 présentations lors de conférences scientifiques et 83 articles publiés, le médecin est une figure éminente dans le domaine, membre de plusieurs sociétés prestigieuses d'oncologie gynécologique.<\/p>

Le docteur est professeur d'urologie et chef de la section d'urologie au Centre médical Rabin, spécialisé dans la reconstruction de la vessie, la prostatectomie robotique et les chirurgies du cancer préservant les nerfs. Fondateur du département d'oncourologie à l'hôpital Beilinson, le docteur a publié plus de 100 articles scientifiques et est analyste de publications significatives en uro-oncologie.<\/p>

Impliqué dans la recherche clinique mondiale, le docteur collabore avec l'Institut Weizmann des Sciences et l'Université de Tel Aviv et siège au conseil d'organisations internationales de recherche en uro-oncologie.<\/p>

Le médecin se spécialise dans le diagnostic d'une gamme de cancers, y compris le cancer du foie, du poumon, de la prostate, de l'estomac, des glandes surrénales, le cancer corticosurrénalien, du sein, de l'œsophage et le mésothéliome péritonéal. Le médecin a été reconnu par de nombreux prix pour ses contributions à l'éducation médicale et à la recherche, tels qu'un Certificat de Mérite pour les présentations de recherche et Magna Cum Lauda pour son travail sur la thrombose de la veine porte chez les candidats à la transplantation hépatique. Le médecin est également membre de plusieurs sociétés prestigieuses, y compris la Société Européenne de Radiologie Gastro-intestinale et Abdominale et la Société Radiologique d'Amérique du Nord.<\/p>

Le médecin est un chirurgien certifié avec une vaste expérience en chirurgie mini-invasive et robotique. Spécialisé dans ces techniques chirurgicales avancées, le médecin exerce au Centre Médical Sourasky, où il applique son expertise pour améliorer les résultats des patients.<\/p>

Le médecin est spécialisé en chirurgie colorectale, pancréatique et gastro-intestinale, avec une expertise particulière dans les procédures de Whipple. Avec plus de 45 ans de pratique, le médecin est reconnu comme l'un des principaux chirurgiens de Whipple en Israël.<\/p>

Le médecin est un spécialiste en médecine nucléaire avec 40 ans d'expérience, se concentrant sur l'imagerie hybride, l'imagerie oncologique et l'imagerie moléculaire du sein. Le médecin travaille au Centre Médical Sourasky et a une spécialisation en médecine nucléaire du Centre Médical Rambam.<\/p>

Le médecin détient un MD de la Faculté de Médecine Sackler, Université de Tel Aviv, et un PhD du Technion - Institut de Technologie d'Israël, avec des études supplémentaires complétées à l'Université Dalhousie, Canada.<\/p>

Dr. Ram (Rami) Palti is an orthopedic hand and upper limb surgeon. He has over 20 years of experience at the Hand Surgery Unit of Sheba Medical Center. He focuses on reconstructive surgery for congenital hand anomalies and deformity correction. He also performs complex microsurgery, nerve repair, and tendon reconstruction.

He earned his MD from Tel Aviv University. He completed an orthopedic residency at Sheba Medical Center. He completed fellowships in Upper Extremity Surgery at NYU Hospital for Joint Diseases and in Hand, Elbow and Peripheral Nerve Surgery at Royal North Shore Hospital. He also received advanced training in congenital upper limb surgery at Westmead Children’s Hospital.

He is a certified medical expert for the Israeli National Insurance Institute. He consults for the Israeli Ministry of Defense Rehabilitation Department and advises legal and government bodies. His practice emphasizes precise microsurgery with functional rehabilitation.

Le médecin a obtenu son diplôme de la Faculté de médecine de l'Université hébraïque en 1987 et se spécialise en chirurgie et chirurgie colorectale. Affilié au Centre médical Hadassah, le médecin est instructeur en chirurgie depuis 1995, conférencier depuis 1999 et conférencier principal depuis 2005. Le médecin dirige le programme des étudiants en médecine au département de chirurgie depuis 1997 et est directeur du programme de résidence au département de chirurgie depuis 2000. Certifié en chirurgie générale en Israël depuis 1998, le médecin est également membre de diverses associations chirurgicales.<\/p>

Dr. Boaz Liberman, MD, is an orthopedic oncologist and sarcoma surgeon for adults and children. He directs the Orthopedic Oncology Unit and serves as Vice Head of Orthopedic Surgery at Sheba Medical Center. His focus is limb-sparing cancer surgery with functional reconstruction. He performs complex joint reconstruction, revision arthroplasty, MRgFUS, and reconstruction after bone metastases.

Education and training: MD, Tel Aviv University. Orthopedic surgery residency, Sheba Medical Center. Fellowships in Adult Reconstruction at Mount Sinai Hospital, Toronto, and in Orthopedic Oncology at Mount Sinai Hospital and Princess Margaret Cancer Centre. He is board-certified in Orthopedic Surgery and in Orthopedic Oncology Surgery. He is a Clinical Instructor at Tel Aviv University. Memberships include the Israel Medical Association, Israel Orthopedic Association, AATB, and EATB. He also serves on national advisory committees. His research covers bone and soft tissue sarcomas, serum markers, imaging-guided therapies, MRI arthrography, and the biomechanics of bone treated with MRgFUS.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.